Infusion Partners, 11C

Form 483 issued January 26, 2018 · Canf i e ld, Ohio

Inspection
Jan 22 – Jan 26, 2018
Observations
10
Pages
6
FEI number
3013995728

In short: On January 26, 2018, FDA issued a Form 483 with 10 observations to Infusion Partners, 11C in Canf i e ld, Ohio (FEI 3013995728) after an inspection that ran Jan 22 – Jan 26, 2018. The investigators were Lauren N. Howard and Matthew B. Casale.

What FDA observed

Preview: the opening words of each observation
  1. 01
    FDCA 501(a)(2)(A)

    The ISO 5 classified aseptic processing areas had visibly…

  2. 02
    FDCA 501(a)(2)(A)

    Disinfectant contact time (also known as "dwell time") and coverage of the item being disinfected were…

  3. 03
    FDCA 501(a)(2)(A)

    Personnel conducted aseptic manipulations and placed equipment/supplies in an area that blocked the movement of first…

  4. 04
    FDCA 501(a)(2)(A)

    Personnel touched equipment or other surfaces located outside of the ISO 5 classified aseptic processing area…

6 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Infusion Partners, 11C?

FDA listed 10 observations on this Form 483. The opening words of each observation are shown on this page.

Who inspected Infusion Partners, 11C?

Lauren N. Howard and Matthew B. Casale are named on this Form 483, for the inspection of Jan 22 – Jan 26, 2018. Each investigator has a profile showing what they cite most.

When was Infusion Partners, 11C inspected by FDA?

The inspection ran Jan 22 – Jan 26, 2018, and the Form 483 is dated January 26, 2018.

How do I get the full Form 483 for Infusion Partners, 11C?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free